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Picrorhiza scrophulariiﬂoraAn antimalarial medicinal plant Picrorhiza scrophulariiﬂora was chemically investigated as part of our
ongoing research in traditional chinese medicines (TCM). Mass directed fractionation of the active part
of the crude extract led to the isolation of ten main components, three new compounds (1–3) and seven
known compounds (4–10). Compound 10 inhibited the growth of the Plasmodium falciparum 3D7 malar-
ial parasite line, with an IC50 value of 8.3 lM. This compound accounted for 95% of P. falciparum growth
inhibitory activity in the crude extract conﬁrming, for this TCM, that a single compound was responsible
for the antimalarial activity.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY license.Malaria is one of the worlds’ most signiﬁcant human infectious
diseases, with 216 million cases leading to an estimated 655,000
deaths in 2010.1,2 Most morbidity and mortality is caused by par-
asites of the genus Plasmodium, which like other malaria parasites
is transmitted by the bite of female Anopheles mosquitoes.1
Although several drugs are currently available for the prevention
and treatment of malaria, all are now susceptible to parasite drug
resistance or reduced clinical efﬁcacy, including the gold standard
artemisinin combination therapies.3 The increasing problem of
drug-resistant Plasmodium strains means that new therapies are
urgently needed to treat this devastating disease.3
Historically, natural products have played a major role in the
treatment of malaria.4–7 For centuries the indigenous people from
South America have used the bark from the ‘fever tree’, Cinchona
succiruba for the treatment of malaria. Similarly, the Chinese
medicinal plant, Artemisia annua, commonly known as Qinghao,
has been used in China as an antimalarial herbal remedy for hun-
dreds of years.4–7 Subsequent chemical investigations of Cinchona
succiruba and Artemisia annua identiﬁed the major active metabo-
lites to be quinine and artemisinin (Qinghaosu), respectively.4–7Artemisinin is considered one of the most important discoveries
in contemporary herbal research.
Traditional Chinese medicine (TCM) has been regarded as a na-
tional heritage for centuries. Approximately 13,000 kinds of medic-
inal plants have been recorded in China.8 Among them, over 300
are commonly used for antimalarial remedies. In our ongoing effort
in understanding TCM and its action, a collaborative research pro-
ject was established to investigate antimalarial traditional Chinese
medicinal plants. The objective of the project was not only to iden-
tify antimalarial natural products, but also to investigate whether a
TCM’s action is solely associated with a single active component,
an underlying philosophy of western medicine. One hundred anti-
malarial Chinese medicinal herbs recorded in the Chinese Pharma-
copeia were selected and tested in vitro against the malaria
parasite Plasmodium falciparum 3D7 for antimalarial activity. Of
these, 82 extracts showed >50% inhibition at 10 mg/mL, while 35
had >90% inhibition at the same concentration. These results lar-
gely conﬁrmed the traditional knowledge of the antimalarial activ-
ity of the herbal medicines recorded in the Chinese Pharmacopiea.
The crude extract from the rhizomes of a Tibetan Picrorhiza scro-
phulariiﬂora Pennell showed potent activity and was chemically
investigated. Flash chromatography of the crude extract followed
by mass-directed fractionation of the active fraction led to the iso-
lation of three new compounds, scrophuloside C–D (1–2), and heb-
itol III (3), along with seven known compounds, namely, hebitol II
(4),8 scrophuloside B (5),9 scrophenoside B (6),10 scroneoside A
(7),11 picroside-I (8),12 25-(acetyloxy)-2-(b-D-glucopyranosyloxy)-
3,16,20-trihydroxy-9-methyl-19-norlanost-5-en-22-one (9),13 and
5916 H. Wang et al. / Bioorg. Med. Chem. Lett. 23 (2013) 5915–591825-(acetyloxy)-2-(b-D-glucopyranosyloxy)-3,16-dihydroxy-9-methyl-
19-norlanosta-5,23-dien-22-one (10).13
Picrohiza scrophulariiﬂora (Scrophulariaceae) is a perennial dis-
tributed throughout the high altitude region (over 4,400 m) in the
southeast of Tibet and the northwest of Yunnan, China. The plant
has been traditionally used for diarrhea, jaundice and malaria.
The rihizomes of Picrorhiza scrophulariiﬂora (Scrophulariaceae) in
this study collected from Tibet Autonomous Region, China, were
purchased from Bozhou Herbal Medicine Market, Anhui Province
in July, 2011. The dried and ground plant material (300 g) was
exhaustively extracted by MeOH, and then partitioned between
petroleum ether, EtOAc and n-BuOH. Silica gel ﬂash chromatogra-
phy of the EtOAc layer yielded one active fraction which was sub-
jected to LC-MS analysis. Mass-directed puriﬁcation by reverse
phase C18 HPLC led to the isolation of nine major components,
including three new metabolites, scrophuloside C (1, 4.4 mg,
0.0015% dry weight), scrophuloside D (2, 3.3 mg, 0.0011% dry
weight) and hebitol III (3, 1.1 mg. 0.0004% dry weight), along with
seven known compounds, namely, hebitol II (4, 3.2 mg, 0.0011%
dry weight), scrophuloside B (5, 12.5 mg, 0.0042% dry weight),
scrophenoside B (6, 13.3 mg, 0.0044% dry weight), scroneoside A
(7, 3.5 mg, 0.0012% dry weight), picroside-I (8, 63.0 mg, 0.021%
dry weight), 25-(acetyloxy)-2-(b-D-glucopyranosyloxy)-3,16,20-
trihydroxy-9-methyl-19-norlanost-5-en-22-one (9, 435.0 mg,
0.145% dry weight), and 25-(acetyloxy)-2-(b-D-glucopyranosyl-
oxy)-3,16-dihydroxy-9-methyl-19-norlanosta-5,23-dien-22-one (10,
485.3 mg, 0.167% dry weight).
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Scrophuloside C (1)14 was obtained as an optically active color-
less solid with an [a]D value of 74.0. The molecular formula of 1
was determined to be C24H26O9 by HRESIMS (m/z 481.1461
[M+Na]+), with twelve degrees of unsaturation. The 1H NMR spec-
trum of 1 (Table 1) indicated the presence of a cinnamoyl function-
ality, a sugar moiety (dH 3.5–5.5), a 1, 2, 4-trisubstituted benzene
ring, a methyl group (dH 2.34), and a methoxyl group (dH 3.83).
The double bond in the cinnamoyl group was determined as trans
based on its coupling constant (dH 7.64 and 6.63, J 16.0 Hz) (Ta-
ble 1). Twenty three carbon resonances were deduced from the
HSQC and HMBC correlation data. Nine carbon resonances (dC
166.4, 145.2, 134.4, 131.0  3, 128.9  2, and 118.6) were consis-
tent with the presence of a cinnamoyl group. The sugar moiety
was assigned as b-glucose based on its 1H and 13C NMR data and
the coupling constant of the anomeric proton (dH 5.12, J 7.6 Hz).
The formation of the acetyl group and its attachment on C-1 posi-
tion of the tri-substituted benzene ring were established by the
HMBC correlations from the methyl singlet (dH 2.34) to a ketone
carbonyl (dC 196.7) and an aromatic carbon (dC 131.4). Further
HMBC correlation was observed from the methoxyl singlet (dH
3.83) to a aromatic carbon (dC 149.2), indicating the methoxylgroup was attached at C-3 position of the benzene ring. The con-
nectivity was conﬁrmed by the HMBC correlations from the aro-
matic protons (dH 7.17 and 7.45) to the aromatic carbons (dC
123.0, 131.4, 149.2 and 150.9). The HMBC correlation from the glu-
cose H-60 (dH 4.44 and 4.24) to the cinnamoyl carbonyl carbon (dC
166.4) suggested the formation of an ester bond between these
two functional groups. The formation of an ether bond between
the glucose moiety and the tri-substituted benzene ring was deter-
mined by the HMBC correlation from the anomeric proton
(dH 5.12) to the C-4 aromatic carbon (dC 150.9). The planar struc-
ture of 1 was therefore elucidated as 1-O-phenyl-6-O-cinnamoyl-
b-glucopyranoside.
The absolute conﬁguration of the glucose moiety in 1 was deter-
mined by gas chromatography of sugar enantiomers as acetylated thi-
azolidine derivative.15,16 Acid hydrolysis of 1 followed by
derivatization with L-cysteine methyl ester gave a GCMS peak at
17.92 min, same as that of a standard D-glucose derivative, namely
methyl 3-acetyl-2R-(10R,20S,30R,40R,5-pentaacetoxypenta-1-yl)-thia-
zolidine-4R-carboxylate (17.97 min,while L-glucose derivativemethyl
3-acetyl-2R-(10S, 20R, 30S, 40S, 5-pentaacetoxypenta-1-yl)-thiazolidine-
4R-carboxylate at 18.48 min), indicating a D-glucose in the molecule.
Scrophuloside C (1) was therefore identiﬁed as 1-O-(2-methoxy-4-
acetylphenyl)-6-O-(E-cinnamoyl)-ß-D-glucopyranoside.
Scrophuloside D (2)17 was also isolated as an optically active
colorless solid, with an [a]D value of 17.6. Its molecular formula
was determined as C23H24O10 by HRESIMS (m/z 459.1286 [MH]),
indicating 2 mass unit more than that of 2. The comparison of the
1H and 13C NMR data between 2 and 1 suggested that the two com-
pounds possessed similar structural features, the differences being
the absence of an acetyl methyl signal in 2 and a up-ﬁeld shift of
the carbonyl carbon (dC 196.7 in 1 to dC 167.8 in 2). These changes
suggested that the acetyl functionality in 1 was replaced by a car-
boxylic acid in 2, which was supported by the molecular formula of
2. Using the same GCMS method as that for compound 1, the abso-
lute conﬁguration of the glucose in 2 was determined as b-D-glu-
cose (with a retention time of 17.96 min). The structure of
scrophuloside D (2) was therefore elucidated as 1-O-(2-methoxy-
4-carboxylphenyl)-6-O-(E-cinnamoyl)-ß-D-glucopyranoside.
Hebitol III (3)18 was isolated as an amorphous solid with a neg-
ative optical rotation ([a]D –38). Its molecular formula, C21H30O12,
was deduced by HRESIMS, indicating seven degrees of unsatura-
tion. The 1H NMR spectrum of 3 (Table 1) displayed signals for a
cinnamoyl group and sugar moieties (dH 3.04–4.41). The double
bond in the cinnamoyl group was determined as trans based on
its large coupling constant (dH 7.65 and 6.65, J 16.0 Hz). Twenty
one carbon resonances were observed in 13C NMR spectrum in
combination with HSQC and HMBC correlation data. Nine carbon
resonances (dC 166.7, 145.2, 134.5, 129.4  2, 129.1, 128.9  2,
and 118.4) were consistent with the presence of a cinnamoyl
group. Six carbon signals (dC 104.2, 74.1, 76.5, 70.4, 74.2 and
64.3) along with their corresponding 1H NMR signal (dH 3.04–
4.41) indicated the presence of a glucopyranoside unit. The large
coupling constant of the anomeric proton (dH 4.23, J 8.0 Hz) indi-
cated that the glucose unit had a ß-conﬁguration. The remaining
6 carbon resonances (dC 73.4–64.3) were assigned to a mannitol
functionality based on the absence of a low ﬁeld anomeric carbon
(dC 100), and lack of double bond equivalence. Further analysis of
the HSQC and HMBC correlation data conﬁrmed the assignment.
The HMBC correlations from the glucose H-60 (dH 4.41 and 4.17)
to the cinnamoyl C-900 (dC 166.7) suggested the formation of an es-
ter bond between the two functional groups. Further HMBC corre-
lation from the glucose H-10 (dH 4.23) to the mannityl C-6 (dC 73.4)
indicated an ether linkage between the glucose and the mannityl
sub-units. The comparison of the carbon chemical shifts between
compound 3 and the known compound, hebitol II, conﬁrmed the
sugar moiety b-glucopyrannosyl-(1? 6)mannitol.
Table 1
1H and 13C NMR Data for Compounds 1–3 in DMSO-d6
Compound 1a,b Compound 2b,c Compound 3a
Position dC dH (J in Hz) HMBC dC dH (J in Hz) HMBC dC dH (J in Hz) HMBC
1 131.4 124.9 64.3 3.58, dd (11.5, 2.3)
3.36, dd (11.5, 5.8)
2 111.4 7.45d C-1, C-3, C-4, C-6 113.5 7.47, d (1.9) C-3, C-4, C-6, C-8 71.7 3.43d C-4
3 149.2 149.0 70.0 3.62, dd (3.8, 11.5) C-2, C-5
4 150.9 150.6 70.1 3.52, d (8.9)
5 114.7 7.17, d (8.0) C-1, C-3 115.0 7.18, d (8.3) C-1, C-3, C-4 70.1 3.53, d (8.9)
6 123.0 7.45d C-2, C-4 123.3 7.50, dd (8.3, 1.9) C-2, C-4, C-8 73.4 4.03, dd (10.5, 1.3), 3.40d C-10
7 56.1 3.83, s C-3 56.4 3.81, s C-3
8 196.7 167.8
9 26.5 2.34, s C-1, C-8
10 99.7 5.12, d (7.6) C-4 99.7 5.12, d,(7.6) C-4 104.2 4.23, d (8.0) C-6
20 73.5 3.38d 73.5 3.33d C-30 74.1 3.04, t (8.5) C-10 , C-30
30 77.3 3.37d C-20 , C-40 77.2 3.34d C-20 76.5 3.18d C-50
40 70.7 3.37d 70.5 3.23d 70.4 3.15d C-60
50 74.3 3.76, m C-10 74.5 3.74 m 74.2 3.41d C-10
60 63.9 4.44, dd (10.3,1.9)
4.24, dd (10.3, 6.1)
C-50 , C-900 63.8 4.45, dd (11.8, 1.9)
4.19, dd (11.8, 6.7)
C-50 , C-900 64.3 4.41, d (10.3)
4.17, dd (10.3, 6.1)
C-50 , C-900
100 134.4 134.5 134.5
200 128.9 7.72, m C-300 , C-600 , C-700 128.6 7.69, m C-300 , C-400 128.9 7.72d C-100 ,C-700
300 131.0 7.45d C-100 , C-200 129.6 7.43d C-100 129.4 7.41d C-100 ,C-200
400 131.0 7.45d 130.8 7.43d 129.1 7.40d
500 131.0 7.45d C-100 , C-600 129.6 7.43d C-100 129.4 7.41d C-100
600 128.9 7.72, m C-200 , C-400 , C-700 128.6 7.69, m C-400 , C-500 128.9 7.72d C-100 ,C-700
700 145.2 7.64, d (16.0) C-200 , C-800 , C-900 145.6 7.61, d (16.0) C-200 , C-800 , C-900 145.2 7.65, d (16.0) C-200 ,C-800 , C-900
800 118.6 6.63, d (16.0) C-100 , C-900 118.5 6.60, d (16.0) C-100 , C-900 118.4 6.65, d (16.0) C-100 , C-900
900 166.4 166.5 166.7
a Spectra were recorded at 600 MHz for 1H and 150 MHz for 13C using d6-DMSO as solvent at 30 C.
b The 13C NMR spectra were observed from the HSQC and HMBC experiments.
c Spectra were recorded at 500 MHz for 1H and 125 MHz for 13C using d6-DMSO as solvent at 30 C.
d Signals were overlapping.
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to be 1-O-mannityl-6-O-cinnamoyl-ß-glucopyranose.
The GCMS analysis of a peracetylated thiazolidine derivative of
the hydrolyzed 3 established a D-glucose moiety (with a retention
time of 17.93 min) as in 1 and 2. The attempt to isolate the manni-
tol moiety form the hydrolyzed mixture, measure its optical rota-
tion, and therefore determine the absolute conﬁguration of
mannitol was hindered by the small quantity of compound 3. Heb-
itol III (3) was therefore determined as 1-O-mannityl-6-O-(E-cin-
namoyl)-ß-D-glucopyranose.
Seven known compounds, namely hebitol II (4),8 scrophuloside
B (5),9 scrophenoside B (6),10 scroneoside A (7),11 picroside-I (8),12
25-(acetyloxy)-2-(b-D-glucopyranosyloxy)-3,16,20-trihydroxy-9-
methyl-19-norlanost-5-en-22-one (9),13 and 25-(acetyloxy)-2-(b-
D-glucopyranosyloxy)-3,16-dihydroxy-9-methyl-19-norlanosta-5,
23-dien-22-one (10),13 were also isolated from the active fraction
of Picrorhiza scrophulariiﬂora. These compounds were previously
reported from the plants Picrorhiza scrophulariiﬂora and Picrorhiza
kurroa and their 1H and 13C NMR data were identical to those re-
ported in the literature.
The antimalarial activity of the crude extracts and the isolated
pure compounds (1–10) were evaluated in vitro against P. falcipa-
rum 3D7 malaria parasites. Chloroquine was used as positive con-
trol which had an IC50 value of 0.018 ± 0.002 lM. Compounds 1–9
all had IC50 > 25 lM, while 10 had an IC50 value of 8.3 ± 0.6 lM,
and an IC90 value of 17.3 ± 1.6 lM. Compounds 9 and 10 were
the two main components in the active fraction, and the only
structural difference is a double bond between C-23 and C-24.
Accordingly, the presence of a a,ß-unsaturated carbonyl group in
compound 10 may be important for its antimalarial activity. Since
compound 10 has a Michael acceptor functionality,19,20 we also
tested its activity against a noncancer cell line, neonatal foreskin
ﬁbroblast (NFF). It showed no cytotoxicity to NFF cells at the con-
centration of up to 100 lM.The crude extract of Picrorhiza scrophulariiﬂora had 95% inhibi-
tion against P. falciparum 3D7 malaria parasites at the concentra-
tion of 10 mg/mL. A calculated IC95 for compound 10 was
obtained based on the activity of the crude extract, the percentage
yield of compound 10 and its molecular weight. The results
showed that the calculated IC95 (23.5 lM) of 10 was comparable
with that of the experimental IC90 (17.3 lM), suggesting that the
antimalarial activity of this TCM, Picrorhiza scrophulariiﬂora, was
contributed mainly by a single component. Given artemisinin (Qin-
ghaosu) was also the single major antimalarial component identi-
ﬁed from Artemisia annua, perhaps the anti-parasitic activity of
TCM is controlled by singlecompounds rather than multiple com-
ponents in TCMs effective against other diseases. Further isolation
and activity evaluation of antimalarial Chinese herbal medicines is
currently ongoing. Results will not only lead to some interesting
bioactive natural products, but also shed light on whether antima-
larial TCMs contain single or multiple active constituents.
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